GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Dividend Payout Ratio

ME Therapeutics Holding (XCNQ:METX) Dividend Payout Ratio : 0.00 (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Dividend Payout Ratio?

ME Therapeutics Holding's dividend payout ratio for the months ended in Feb. 2024 was 0.00.

The historical rank and industry rank for ME Therapeutics Holding's Dividend Payout Ratio or its related term are showing as below:


XCNQ:METX's Dividend Payout Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 0.435
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-14), the Dividend Yield % of ME Therapeutics Holding is 0.00%.

ME Therapeutics Holding's Dividends per Share for the months ended in Feb. 2024 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

ME Therapeutics Holding Dividend Payout Ratio Historical Data

The historical data trend for ME Therapeutics Holding's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Dividend Payout Ratio Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Dividend Payout Ratio
- -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Dividend Payout Ratio Get a 7-Day Free Trial - - - - -

Competitive Comparison of ME Therapeutics Holding's Dividend Payout Ratio

For the Biotechnology subindustry, ME Therapeutics Holding's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ME Therapeutics Holding's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ME Therapeutics Holding's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where ME Therapeutics Holding's Dividend Payout Ratio falls into.


ME Therapeutics Holding Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

ME Therapeutics Holding's Dividend Payout Ratio for the fiscal year that ended in Aug. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Aug. 2023 )/ EPS without NRI (A: Aug. 2023 )
=0/ -0.04
=N/A

ME Therapeutics Holding's Dividend Payout Ratio for the quarter that ended in Feb. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Feb. 2024 )/ EPS without NRI (Q: Feb. 2024 )
=0/ -0.01
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ME Therapeutics Holding (XCNQ:METX) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

ME Therapeutics Holding Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Dividend Payout Ratio
Comparable Companies
Traded in Other Exchanges
Q9T:Germany
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
Website
https://www.metherapeutics.com
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines